Current controversies in heart failure with a preserved ejection fraction

Future Cardiology

Volumn 6, Issue 1, 2010, Pages 97-111

  MacIver, David H ^a  

^a TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

Author keywords

Diastolic dysfunction; Diastolic heart failure; Ejection fraction; Heart failure; HFNEF; HFPEF; Pathogenesis; Pathophysiology

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; DIGOXIN; DIURETIC AGENT; NEBIVOLOL; NESIRITIDE; PERINDOPRIL; RAMIPRIL; SILDENAFIL; VERAPAMIL;

CLINICAL TRIAL; DIASTOLIC DYSFUNCTION; DIASTOLIC HEART FAILURE; DYSPNEA; ECHOCARDIOGRAPHY; EXERCISE; FATIGUE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CONTRACTILITY; HOSPITAL ADMISSION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LUNG EDEMA; MORTALITY; MYOCARDITIS; NONHUMAN; PATHOGENESIS; PERIPHERAL EDEMA; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SYSTOLIC DYSFUNCTION;

HEART FAILURE, DIASTOLIC; HEART FAILURE, SYSTOLIC; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; PROGNOSIS; STROKE VOLUME; TERMINOLOGY AS TOPIC; VENTRICULAR FUNCTION, LEFT;

EID: 73949149560     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.09.56     Document Type: Review

References (114)

1. Caruana L, Petrie M, Davie A, McMurray J: Do patients with suspected heart failure and preserved left ventricular systolic function suffer from diastolic heart failure or from misdiagnosis? A prospective descriptive study. Br. Med. J. 321(7255), 215-218 (2000).
2. Paulus W, Tschope C, Sanderson J et al.: How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur. Heart J. 28, 2539-2550 (2007). (Pubitemid 47614269)
3. Zile M, LeWinter M: Left ventricular end-diastolic volume is normal in patients with heart failure and a normal ejection fraction. A renewed consensus in diastolic heart failure. J. Am. Coll. Cardiol. 49(9), 982-985 (2007).
4. Kitzman D, Gardin J, Gottdiener J, Arnold A, Boineau R, Aurigemma G: Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS research group. Am. J. Cardiol. 87, 413-419 (2001).
5. Yip G, Wang M, Zhang Y, Fung J, Ho P, Sanderson J: Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? Heart 87(2), 121-125 (2002).
6. Kitzman D: Diastolic dysfunction: one piece of the heart failure with normal ejection fraction puzzle. Circulation 117(16), 2044 (2008).
7. Burkhoff D, Maurer M, Packer M: Heart failure with a normal ejection fraction. Is it really a disorder of diastolic function? Circulation 107(5), 656-658 (2003).
8. Lenzen M, Scholte op Reimer W, Boersma E et al.: Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur. Heart J. 25(14), 1214-1220 (2004).
9. Owan T, Hodge D, Herges R, Jacobsen S, Roger V, Redfield M: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med. 355(3), 251 (2006).
10. Hogg K, Swedberg K, McMurray J: Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis. J. Am. Coll. Cardiol. 43(3), 317-327 (2004).
11. Cleland J, Swedberg K, Follath F et al.: The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe: Part 1: patient characteristics and diagnosis. Eur. Heart J. 24(5), 442-463 (2003). (Pubitemid 36286187)
12. Yancy C, Lopatin M, Stevenson L, De Marco T, Fonarow G: Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function. A report from the acute decompensated heart failure national registry (ADHERE) database. J. Am. Coll. Cardiol. 47(1), 76-84 (2006). (Pubitemid 43005168)
13. McMurray J, Carson P, Komajda M et al.: Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. Eur. J. Heart Fail. 10(2), 149-156 (2008).
14. Lee D, Gona P, Vasan R et al.: Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: Insights from the Framingham Heart Study of the National Heart, Lung, and Blood Institute. Circulation 119(24), 3070 (2009).
15. Maurer M, Burkhoff D, Fried L, Gottdiener J, King D, Kitzman D: Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction. The cardiovascular health study. J. Am. Coll. Cardiol. 49(9), 972-981 (2007).
16. Maurer M, King D, El-Khoury R, Packer M, Burkhoff D: Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms. J. Card. Fail. 11(3), 177-187 (2005).
17. Baicu C, Zile M, Aurigemma G, Gaasch W: Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation 111(18), 2306-2312 (2005).
18. Lam C, Roger V, Rodeheffer R et al.: Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 115(15), 1982-1990 (2007).
19. Kitzman D, Little W, Brubaker P et al.: Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. J. Am. Med. Assoc. 288(17), 2144-2150 (2002).
20. Zile M, Baicu C, Gaasch W: Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. N. Engl. J. Med. 350(19), 1953-1959 (2004).
21. Wong C, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick T: Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 110(19), 3081-3087 (2004).
22. Pieske B, Wachter R: Impact of diabetes and hypertension on the heart. Curr. Opin. Cardiol. 23(4), 340 (2008).
23. Kindermann M, Reil J, Pieske B, van Veldhuisen D, Böhm M: Heart failure with normal left ventricular ejection fraction: what is the evidence? Trends Cardiovasc. Med. 18(8), 280-292 (2008).
24. van Heerebeek L, Borbely A, Niessen H et al.: Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 113, 1966-1973 (2006).
25. Farr M, Lang C, LaManca J et al.: Cardiopulmonary exercise variables in diastolic versus systolic heart failure. Am. J. Cardiol. 102(2), 203-206 (2008).
26. Harrington D, Anker S, Coats A: Preservation of exercise capacity and lack of peripheral changes in asymptomatic patients with severely impaired left ventricular function. Eur. Heart J. 22(5), 392-399 (2001).
27. Kessler KM: Heart failure with normal systolic function: update of prevalence, differential diagnosis, prognosis, and therapy. Arch. Intern. Med. 148(10), 2109-2111 (1988).
28. Grossman W: Defining diastolic dysfunction. Circulation 101(17), 2020-2021 (2000).
29. Zile M, Gaasch W, Carroll J et al.: Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 104(7), 779-782 (2001).
30. Kitzman D, Higginbotham M, Cobb F, Sheikh K, Sullivan M: Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J. Am. Coll. Cardiol. 17(5), 1065-1072 (1991).
31. Redfield M, Jacobsen S, Burnett JC Jr, Mahoney D, Bailey K, Rodeheffer R: Burden of systolic and diastolic ventricular dysfunction in the community appreciating the scope of the heart failure epidemic. J. Am. Med. Assoc. 289(2), 194-202 (2003).
32. Mantero A, Gentile F, Gualtierotti C et al.: Left ventricular diastolic parameters in 288 normal subjects from 20 to 80 years old. Eur. Heart J. 16(1), 94 (1995).
33. Yip G, Zhang Y, Tan P et al.: Left ventricular long-axis changes in early diastole and systole: impact of systolic function on diastole. Clin. Sci. 102(5), 515-522 (2002).
34. Bursi F, Weston S, Redfield M et al.: Systolic and diastolic heart failure in the community. J. Am. Med. Assoc. 296(18), 2209-2216 (2006).
35. Wilson J, Rayos G, Yeoh T, Gothard P, Bak K: Dissociation between exertional symptoms and circulatory function in patients with heart failure. Circulation 92(1), 47-53 (1995).
36. Abramov D, Cohen R, Katz S, Mancini D, Maurer M: Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fractions. Am. J. Cardiol. 102(8), 1069-1072 (2008).
37. Klotz S, Hay I, Zhang G, Maurer M, Wang J, Burkhoff D: Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction. Hypertension 47(5), 901-911 (2006).
38. Kawaguchi M, Hay I, Fetics B, Kass D: Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 107(5), 714-720 (2003).
39. Maurer M, Kronzon I, Burkhoff D: Ventricular pump function in heart failure with normal ejection fraction: insights from pressure-volume measurements. Prog. Cardiovasc. Dis. 49(3), 182-195 (2006).
40. Heusch G: Diastolic heart failure: a misNOmer. Basic Res. Cardiol. 104, 465-467 (2009).
41. Brutsaert D: Cardiac dysfunction in heart failure: the cardiologist's love affair with time. Prog. Cardiovasc. Dis. 49(3), 157-181 (2006).
42. De Keulenaer G, Brutsaert D: Diastolic heart failure: a separate disease or selection bias? Prog. Cardiovasc. Dis. 49(4), 275-283 (2007).
43. De Keulenaer G, Brutsaert D: Systolic and diastolic heart failure: different phenotypes of the same disease? Eur. J. Heart Fail. 9(2), 136-143 (2007). (Pubitemid 46394077)
44. Berenji K, Drazner M, Rothermel B, Hill J: Does load-induced ventricular hypertrophy progress to systolic heart failure? Am. J. Physiol. Heart Circ. Physiol. 289(1), 8-16 (2005).
45. MacIver D: A mathematical model of left ventricular contraction and its application in heart disease. In: Repair and Redesign of Physiological Systems. Atherton M, Collins M, Dayer M (Eds). WITpress, Boston, MA, USA 65-86 (2008).
46. Anderson R, Ho S, Redmann K, Sanchez-Quintana D, Lunkenheimer P: The anatomical arrangement of the myocardial cells making up the ventricular mass. Eur. J. Cardiothorac. Surg. 28(4), 517-525 (2005).
47. Yip G, Ho P, Woo K, Sanderson J: Comparison of frequencies of left ventricular systolic and diastolic heart failure in Chinese living in Hong Kong. Am. J. Cardiol. 84(5), 563-567 (1999).
48. Petrie M, Caruana L, Berry C, McMurray J: 'Diastolic heart failure' or heart failure caused by subtle left ventricular systolic dysfunction? Heart 87(1), 29-31 (2002).
49. Thomas J, Popovic Z: Assessment of left ventricular function by cardiac ultrasound. J. Am. Coll. Cardiol. 48(10), 2012-2025 (2006).
50. García E, Perna E, Farías E et al.: Reduced systolic performance by tissue Doppler in patients with preserved and abnormal ejection fraction: new insights in chronic heart failure. Int. J. Cardiol. 108(2), 181-188 (2006).
51. Yu C, Lin H, Yang H, Kong S, Zhang Q, Lee S: Progression of systolic abnormalities in patients with 'isolated' diastolic heart failure and diastolic dysfunction. Circulation 105(10), 1195-1201 (2002).
52. Nikitin N, Witte K, Clark A, Cleland J: Color tissue Doppler-derived long-axis left ventricular function in heart failure with preserved global systolic function. Am. J. Cardiol. 90(10), 1174-1177 (2002).
53. Bruch C, Gradaus R, Gunia S, Breithardt G, Wichter T: Doppler tissue analysis of mitral annular velocities: evidence for systolic abnormalities in patients with diastolic heart failure. J. Am. Soc. Echocardiogr. 16(10), 1031-1036 (2003).
54. Pellerin D, Sharma R, Elliott P, Veyrat C: Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function. Heart 89(Suppl. III), III9-III17 (2003).
55. Wang J, Khoury D, Yue Y, Torre-Amione G, Nagueh S: Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur. Heart J. 29, 1283-1289 (2008).
56. Sanderson J: Heart failure with a normal ejection fraction. Heart 93(2), 155-158 (2007).
57. Kono M, Kisanuki A, Takasaki K et al.: Left ventricular systolic function is abnormal in diastolic heart failure: re-assessment of systolic function using cardiac time interval analysis. J. Cardiol. 53(3), 437-446 (2009).
58. Vinereanu D, Nicolaides E, Tweddel A, Fraser A: 'Pure' diastolic dysfunction is associated with long-axis systolic dysfunction. Implications for the diagnosis and classification of heart failure. Eur. J. Heart Fail. 7(5), 820-828 (2005).
59. Vinereanu D, Lim P, Frenneaux M, Fraser A: Reduced myocardial velocities of left ventricular long-axis contraction identify both systolic and diastolic heart failure - a comparison with brain natriuretic peptide. Eur. J. Heart Fail. 7(4), 512-519 (2005).
60. Sanderson J, Fraser A: Systolic dysfunction in heart failure with a normal ejection fraction: Echo-Doppler measurements. Prog. Cardiovasc. Dis. 49(3), 196-206 (2006). (Pubitemid 44648176)
61. Alpert N, Hamrell B, Halpern W: Mechanical and biochemical correlates of cardiac hypertrophy. Circ. Res. 34, 1171-1181 (1974).
62. Bing O, Matsushita S, Fanburg B, Levine H: Mechanical properties of rat cardiac muscle during experimental hypertrophy. Circ. Res. 28(2), 234-245 (1971).
63. Spann J, Buccino R, Sonnenblick E, Braunwald E: Contractile state of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy and heart failure. Circ. Res. 21(3), 341-354 (1967).
64. Jacob R, Vogt M, Rupp H: Pathophysiological mechanisms in cardiac insufficiency induced by chronic pressure overload - an attempt to analyze specific factors in animal experiment. Basic Res. Cardiol. 81(1), 203-216 (1986).
65. Hamrell B, Hultgren P: Sarcomere shortening in pressure overload hypertrophy. Fred. Proc. 45, 2591-2596 (1986).
66. Capasso J, Strobeck J, Sonnenblick E: Myocardial mechanical alterations during gradual onset long-term hypertension in rats. Am. J. Physiol. Heart Circ. Physiol. 241(3), 435-441 (1981).
67. Schaible T, Ciambrone G, Capasso J, Scheuer J: Cardiac conditioning ameliorates cardiac dysfunction associated with renal hypertension in rats. J. Clin. Invest. 73(4), 1086-1094 (1984).
68. Takahashi M, Sasayama S, Kawai C, Kotoura H: Contractile performance of the hypertrophied ventricle in patients with systemic hypertension. Circulation 62(1), 116-126 (1980).
69. Gaasch W, Zile M, Hoshino P, Apstein C, Blaustein A: Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy. Circulation 79(4), 872-883 (1989).
70. Shimizu G, Hirota Y, Kita Y, Kawamura K, Saito T, Gaasch W: Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy. Circulation 83(5), 1676-1684 (1991).
71. Fang ZF, Leano R, Marwick T: Relationship between longitudinal and radial contractility in subclinical diabetic heart disease. Clin. Sci. 106, 53-60 (2004).
72. Aurigemma G, Silver K, Priest M, Gaasch W: Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J. Am. Coll. Cardiol. 26(1), 195-202 (1995).
73. Vinch C, Aurigemma G, Simon H, Hill J, Tighe D, Meyer T: Analysis of left ventricular systolic function using midwall mechanics in patients > 60 years of age with hypertensive heart disease and heart failure. Am. J. Cardiol. 96(9), 1299-1303 (2005).
74. Tan Y, Wenzelburger F, Lee E et al.: The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J. Am. Coll. Cardiol. 54(1), 36 (2009).
75. MacIver D, Green N, Gammage M: Effects of experimental hypertension on phosphoinositide and proto-oncogene expression in cardiovascular tissues. J. Vasc. Biol. 30, 13-22 (1993).
76. Hilfiker-Kleiner D, Landmesser U, Drexler H: Molecular mechanisms in heart failure. Focus on cardiac hypertrophy, inflammation, angiogenesis, and apoptosis. J. Am. Coll. Cardiol. 48(9S), 56-66 (2006).
77. Miyajima E, Shintani Y, Yonezawa H: A new technique for quantitative assessment of the heart in hypertension. Am. J. Hypertens. 18(5S), A3-A3 (2005).
78. Poulsen S, Søgaard P, Nielsen-Kudsk J, Egeblad H: Recovery of left ventricular systolic longitudinal strain after valve replacement in aortic stenosis and relation to natriuretic peptides. J. Am. Soc. Echocardiogr. 20(7), 877-884 (2007).
79. Nagueh S, Bachinski L, Meyer D et al.: Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 104(2), 128-130 (2001).
80. Koyama J, Ray-Sequin P, Falk R: Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 107(19), 2446-2452 (2003).
81. Palka P, Macdonald G, Lange A, Burstow D: The role of Doppler left ventricular filling indexes and Doppler tissue echocardiography in the assessment of cardiac involvement in hereditary hemochromatosis. J. Am. Soc. Echocardiogr. 15(9), 884-890 (2002).
82. Galderisi M: Diastolic dysfunction and diabetic cardiomyopathy. Evaluation by Doppler echocardiography. J. Am. Coll. Cardiol. 48(8), 1548-1551 (2006).
83. Weidemann F, Breunig F, Beer M et al.: Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease. A prospective strain rate imaging study. Circulation 108(11), 1299-1301 (2003).
84. Abhayaratna W, Marwick T, Smith W, Becker N: Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey. Heart 92(9), 1259-1264 (2006).
85. Melenovsky V, Borlaug B, Rosen B et al.: Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the Urban Baltimore community. The role of atrial remodeling/dysfunction. J. Am. Coll. Cardiol. 49(2), 198-207 (2007).
86. MacIver D, Townsend M: A novel mechanism of heart failure with normal ejection fraction. Heart 94(4), 446-449 (2008).
87. MacIver D: Is remodeling the dominant compensatory mechanism in both chronic heart failure with preserved and reduced left ventricular ejection fraction? Basic Res. Cardiol. DOI: 10.1007/s00395-009-0063-x (2009) (Epub ahead of print).
88. Phan T, Abozguia K, Nallur Shivu G et al.: Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. J. Am. Coll. Cardiol. 54(5), 402-409 (2009).
89. Liu C, Ting C, Lawrence W, Maughan W, Chang M, Kass D: Diminished contractile response to increased heart rate in intact human left ventricular hypertrophy. Systolic versus diastolic determinants. Circulation 88(4), 1893 (1993).
90. Borlaug B, Melenovsky V, Russell S et al.: Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 114(20), 2138 (2006).
91. Cohen-Solal A, Logeart D, Tartiere J: 'Diastolic' heart failure, overlooked systolic dysfunction, altered ventriculo-arterial coupling or limitation of cardiac reserve? Int. J. Cardiol. 128, 299-303 (2008).
92. Bhatia R, Tu J, Lee D et al.: Outcome of heart failure with preserved ejection fraction in a population-based study. N. Engl. J. Med. 355(3), 260 (2006).
93. Park S, Miyazaki C, Bruce C, Ommen S, Miller F, Oh J: Left ventricular torsion by two-dimensional speckle tracking echocardiography in patients with diastolic dysfunction and normal ejection fraction. J. Am. Soc. Echocardiogr. 21(10), 1129-1137 (2008).
94. Borg A, Ray S: A unifying framework for understanding heart failure? response to 'left ventricular torsion by two-dimensional speckle tracking echocardiography in patients with diastolic dysfunction and normal ejection fraction'. J. Am. Soc. Echocardiogr. 22(3), 318-320 (2009).
95. Lam C, Roger V, Rodeheffer R, Borlaug B, Enders F, Redfield M: Pulmonary hypertension in heart failure with preserved ejection fraction a community-based study. J. Am. Coll. Cardiol. 53(13), 1119-1126 (2009).
96. Bitter T, Faber L, Hering D, Langer C, Horstkotte D, Oldenburg O: Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur. J. Heart Fail. 11(6), 602-608 (2009).
97. Klotz S, Hay I, Zhang G, Maurer M, Wang J, Burkhoff D: Development of heart failure in chronic hypertensive Dahl rats. Focus on heart failure with preserved ejection fraction. Hypertension 47(5), 901-911 (2006).
98. MacIver D: Surgical ventricular reconstruction: an oversimplified hypothesis? N. Engl. J. Med. 361, 529-532 (2009).
99. Banerjee P, Clark A, Nikitin N, Cleland J: Diastolic heart failure. Paroxysmal or chronic? Eur. J. Heart Fail. 6(4), 427 (2004).
100. Fung J, Sanderson J, Yip G, Zhang Q, Yu C: Impact of atrial fibrillation in heart failure with normal ejection fraction: a clinical and echocardiographic study. J. Card. Fail. 13(8), 649-655 (2007).
101. Maurer M, Spevack D, Burkhoff D, Kronzon I: Diastolic dysfunction. Can it be diagnosed by Doppler echocardiography? J. Am. Coll. Cardiol. 44(8), 1543-1549 (2004).
102. Solomon S, Anavekar N, Skali H et al.: Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 112(24), 3738-3744 (2005).
103. Vasan R, Larson M, Benjamin E, Evans J, Reiss C, Levy D: Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction prevalence and mortality in a population-based cohort. J. Am. Coll. Cardiol. 33(7), 1948-1955 (1999).
104. Swedberg K, Cleland J, Dargie H et al.: Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005) The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur. Heart J. 26(11), 1115-1140 (2005).
105. Flather M, Shibata M, Coats A et al.: Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur. Heart J. 26(3), 215-225 (2005).
106. McMurray J: Making sense of SENIORS. Eur. Heart J. 26(3), 203-206 (2005).
107. Setaro J, Zaret B, Schulman D, Black H, Soufer R: Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am. J. Cardiol. 66(12), 981-986 (1990).
108. Cleland J, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J; PEP-CHF Investigators: The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur. Heart J. 27, 2338-2345 (2006).
109. Yip G, Wang M, Wang T et al.: The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction. Heart 94(5), 573 (2008).
110. Yusuf S, Pfeffer M, Swedberg K et al.: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362(9386), 777-781 (2003).
111. Persson H, Lonn E, Edner M et al.: Diastolic dysfunction in heart failure with preserved systolic function: Need for objective evidence results from the CHARM echocardiographic Substudy - CHARMES. J. Am. Coll. Cardiol. 49(6), 687-694 (2007).
112. Massie B, Carson P, McMurray J et al.: I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction. N. Engl. J. Med. 359(23), 2456 (2008).
113. Ahmed A, Rich M, Fleg J et al.: Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 114(5), 397 (2006).
114. Lentner C: Geigy scientific tables - cardiac dimensions, volumes and masses: In: Volume 5 Heart and Circulation. Ciba-Geigy. West Caldwell, NJ USA, (1990).